| Literature DB >> 22015258 |
Sijun Dong1, Yoshiyuki Furutani, Yumiko Suto, Michiko Furutani, Yun Zhu, Makoto Yoneyama, Taichi Kato, Hiroyuki Itabe, Toshio Nishikawa, Hirofumi Tomimatsu, Takeshi Tanaka, Hiroshi Kasanuki, Tomoh Masaki, Ryoiti Kiyama, Rumiko Matsuoka.
Abstract
Agaricus blazei (A. blazei) Murrill mycelia-dikaryon has attracted the attention of scientists and clinicians worldwide owing to its potential for the treatment of cancer. However, little is known about its effect on other pathologies. This study sought to extend the potential medical usefulness of A. blazei for preventing vascular damage and to unravel its mechanism of action. The A. blazei extract showed estrogen-like activity in both gene expression profiling and a luciferase assay. Indeed, the extract inhibited oxidized low-density lipoprotein-stimulated activation of Erk1/2, Akt and p38 in HUVECs and macrophage-derived TIB-67 cells. Moreover, the extract enhanced transcription of the glutathione peroxidase 3 (GPX3), α-synuclein (SNCA) and endothelial nitrogen-oxide synthase (eNOS) genes. Furthermore, atherosclerotic lesions in rabbits were reduced by intake of A. blazei powder. Therefore, A. blazei may be useful for preventing atherosclerosis via dual roles in cell signaling, suppression of macrophage development and the recovery of endothelial cells from vascular damage. Copyright ÂEntities:
Mesh:
Substances:
Year: 2011 PMID: 22015258 DOI: 10.1016/j.micres.2011.09.003
Source DB: PubMed Journal: Microbiol Res ISSN: 0944-5013 Impact factor: 5.415